Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Howell

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Drug and Alcohol Review|April 29, 2025
Age, period and cohort trends in hospital admissions for alcohol-related liver disease in Australia, 1993-2020Michael Livingston, Will Gilmore, Nic Taylor, et al.
Scientific Reports|February 5, 2022
A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab StudyAnn M Farrell, Dianna J Magliano, Jonathan E Shaw, et al.
Journal of Viral Hepatitis|February 26, 2019
Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugsNed H Latham, Alisa Pedrana, Joseph S Doyle, et al.
Journal of Viral Hepatitis|December 20, 2019
Enhancing the hepatitis B care cascade in Australia: A cost-effectiveness modelYinzong Xiao, Jessica Howell, Caroline van Gemert, et al.
BMC Health Services Research|January 16, 2024
Patients' experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluationBridget Draper, Win Lei Yee, Anna Bowring, et al.
Journal of Gastroenterology and Hepatology|August 8, 2015
The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New ZealandJessica Howell, Glenda Balderson, Margaret Hellard, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 20, 2020
A rat subchronic study transcriptional point of departure estimates a carcinogenicity study apical point of departureEnrica Bianchi, Eduardo Costa, Zhongyu June Yan, et al.
BMC Public Health|October 25, 2019
'Teach-back' is a simple communication tool that improves disease knowledge in people with chronic hepatitis B - a pilot randomized controlled studySophie Tran, Gabrielle Bennett, Jacqui Richmond, et al.
The Lancet Regional Health. Western Pacific|January 13, 2022
Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patientsBridget Draper, Win Lei Yee, Alisa Pedrana, et al.
Journal of Viral Hepatitis|August 30, 2020
In support of community-based hepatitis C treatment with triage of people at risk of cirrhosis to specialist careAmanda J Wade, Joseph S Doyle, Bridget Draper, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Drug and Alcohol Review|April 29, 2025
Age, period and cohort trends in hospital admissions for alcohol-related liver disease in Australia, 1993-2020Michael Livingston, Will Gilmore, Nic Taylor, et al.
Scientific Reports|February 5, 2022
A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab StudyAnn M Farrell, Dianna J Magliano, Jonathan E Shaw, et al.
Journal of Viral Hepatitis|February 26, 2019
Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugsNed H Latham, Alisa Pedrana, Joseph S Doyle, et al.
Journal of Viral Hepatitis|December 20, 2019
Enhancing the hepatitis B care cascade in Australia: A cost-effectiveness modelYinzong Xiao, Jessica Howell, Caroline van Gemert, et al.
BMC Health Services Research|January 16, 2024
Patients' experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluationBridget Draper, Win Lei Yee, Anna Bowring, et al.
Journal of Gastroenterology and Hepatology|August 8, 2015
The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New ZealandJessica Howell, Glenda Balderson, Margaret Hellard, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 20, 2020
A rat subchronic study transcriptional point of departure estimates a carcinogenicity study apical point of departureEnrica Bianchi, Eduardo Costa, Zhongyu June Yan, et al.
BMC Public Health|October 25, 2019
'Teach-back' is a simple communication tool that improves disease knowledge in people with chronic hepatitis B - a pilot randomized controlled studySophie Tran, Gabrielle Bennett, Jacqui Richmond, et al.
The Lancet Regional Health. Western Pacific|January 13, 2022
Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patientsBridget Draper, Win Lei Yee, Alisa Pedrana, et al.
Journal of Viral Hepatitis|August 30, 2020
In support of community-based hepatitis C treatment with triage of people at risk of cirrhosis to specialist careAmanda J Wade, Joseph S Doyle, Bridget Draper, et al.
Pageof 10